Veeco's BioScope II AFM Selected by the Institute Pasteur De Lille

Veeco Instruments Inc. (Nasdaq: VECO), a leadingsupplier of instrumentation to the nanoscience community, announcedtoday that its recently introduced BioScope(TM) II, an innovative,high-performance atomic force microscope (AFM) designed to facilitateadvanced bioscience research, has been selected for purchase by theInstitute Pasteur de Lille. The Institute Pasteur de Lille is aprivate, non-profit organization dedicated to the prevention andtreatment of disease through research, education and public healthactivities, and is a member of the international network of thePasteur Institutes which has campuses in Lille and Montpellier,France. In addition, Veeco will establish a life sciences lab in theInstitute's facility, and will provide bio-applications scientists andother technology resources to the Institute.

Dr. Frank Lafont, Group Director, Cell Microbiology and PathogenicInfectious Diseases, Institute Pasteur de Lille, stated, "The BioScopeII's superior resolution and ease-of-use with optical microscopes madeit the clear choice for our advanced cell biology research.Furthermore, Veeco's commitment to the bio-research community throughapplications support, dedicated life scientists, and access todevelopment teams made them the right partner for the InstitutePasteur de Lille. It is the Institute Pasteur de Lille's intention tocontinue to forge links between academics and industry in the areas ofcell biology research in order to further the treatment of infectiousand other diseases, as evidenced by this collaboration with Veeco, theworld leader in AFM."

Jeannine Sargent, Executive Vice President, Veeco Metrology andInstrumentation, commented, "We are pleased that our BioScope II hasbeen selected by the Institute Pasteur de Lille, a premier cellbiology research center in Europe. Veeco's goal is to remain at theforefront of worldwide cell biology research and to develop otherinnovative AFM solutions for biologic research and industrialapplications."

Francis Steenbeke, Vice President, Veeco Europe, added, "TheInstitute Pasteur de Lille is important from both an educational andresearch standpoint throughout the European bio-research andindustrial community. Establishing our bio-lab at the Lille site willmake the BioScope II technology and Veeco's applications specialistsreadily accessible to other research centers throughout Europe."

The BioScope II AFM enables novel in-situ techniques for measuringbiological samples in three dimensions, while integrated with aninverted optical or confocal microscope. It is ideal for a wide arrayof cutting-edge bioscience applications, such as spatialidentification of protein molecules and cellular structures,investigations of cell response to mechanical stimulation andnanomanipulation, and in situ pharmacological studies of live cells.Of Veeco's over 7,000 research AFMs installed at universities andnanoscience centers worldwide, approximately 1,500 are currently inuse in bioscience applications. Over 2,000 scientific papers have beenpublished in the field of bio-research citing Veeco AFMs.

About the Institute Pasteur de Lille

The Institute Pasteur de Lille is a non-profit private foundationdedicated to the prevention and treatment of diseases throughbiological research, education and public health activities. TheInstitute was founded in 1894 by Louis Pasteur. Its first Director,Albert Calmette, successfully developed the Bacille Calmette Guerinvaccine. Since its founding, The Institute Pasteur de Lille has hadthree major areas of focus: biological research, public healthapplications and teaching. More than 1,000 scientists, engineers andtechnicians are working in research units and laboratories on theLille campus.

About Veeco

Veeco Instruments Inc. provides solutions for nanoscaleapplications in the worldwide semiconductor, data storage,HB-LED/wireless and scientific research markets. Our Metrologyproducts are used to measure at the nanoscale and our ProcessEquipment tools help create nanoscale devices. Veeco's manufacturingand engineering facilities are located in New York, New Jersey,California, Colorado, Arizona and Minnesota. Global sales and serviceoffices are located throughout the United States, Europe, Japan andAsia Pacific. Additional information on Veeco can be found athttp://www.veeco.com/.

To the extent that this news release discusses expectations aboutmarket condition, market acceptance and future sales of Veeco'sproducts, Veeco's future financial performance, future disclosures, orotherwise makes statements about the future, such statements areforward-looking and are subject to a number of risks and uncertaintiesthat could cause actual results to differ materially from thestatements made. These factors include the challenges of continuingweakness in end market conditions and the cyclical nature of thesemiconductor, data storage, HB-LED wireless and scientific researchmarkets, risks associated with integrating acquired businesses and theacceptance of new products by individual customers and by themarketplace and other factors discussed in the Business Descriptionand Management's Discussion and Analysis sections of Veeco's AnnualReport on Form 10-K, subsequent Quarterly Reports on Form 10-Q andcurrent reports on Form 8-K . Veeco does not undertake any obligationto update any forward-looking statements to reflect future events orcircumstances after the date of such statements.